Returning to the diagnostics industry, Sharon Bracken shares her thoughts on the importance of the AACC meeting, her perspective on the business, and what she looks forward to from this year’s AACC.
As we prepare for AACC in Chicago, Siemens Healthineers is pleased to welcome our new head of Diagnostics, Sharon Bracken. Sharon, it’s exciting to have you with us just in time for this year’s AACC.
Thanks! I’m excited to be back at AACC and in the diagnostics industry, after being away for a few years. I’ve truly missed the customers in the lab and the patients that they serve. It’s especially exciting to be at the helm of Siemens Healthineers. I’ve worked in healthcare diagnostics for over 20 years, in multiple businesses and capacities – and this isn’t just a job, it’s a passion for me.
I’m impressed with the broad portfolio of innovative products and assays that Siemens Healthineers offers. Even more impressive is the degree of talent that we have on the team – we have a global scale and reach that is, in my opinion, unmatched in the industry.
Tell us, why is AACC so important to you?
There has never been a more dynamic time in diagnostics. COVID-19 shined a light on the importance of this industry. The power of diagnostics testing provides greater understanding of overall health and treatment pathways – with Siemens Healthineers at the cutting edge through our diverse portfolio.
AACC is a great venue for us to highlight what we have to offer. It’s the place to learn about emerging trends, explore new opportunities, meet and listen to customers, and collaborate to find new ways of working together – all with the patient in mind. I look forward to engaging with customers and key opinion leaders – and together, to push the envelope of diagnostics innovation and growth as we advance quality care.
What do you hope to share about Siemens Healthineers at AACC?
Since joining Siemens Healthineers in May, I’ve seen how the company’s portfolio exemplifies AACC’s theme – “The Lab and Beyond” – from the Atellica® Solution, to our broad portfolio of assays, to our Point of Care products. This year, we’ll be demonstrating our new systems, including Atellica® CI 19001 and Atellica® CI Max1, which will be shown for the first time in public. But this isn’t just about the latest and greatest technology. It’s about enhancing analytical integration in chemistry, immunoassay, hematology, and hemostasis – and Siemens Healthineers is one of the only companies that can deliver in all four core areas.
What’s more, our innovative assays, which complement our best-in-class instrumentation, tackle numerous disease states – from liver fibrosis, to blood clotting, to cardiac care, to infectious diseases. And we’re keenly focused on other markers as well – in cancer, neurology, and emerging disease trends. At the same time, we continuously evolve our portfolio to accelerate innovation via smarter technology, increased integration, and greater customization – which all lead to better patient care.
These are the promises of diagnostics’ future – and when delivered, are capable of meeting the specific needs of any user, in any clinical environment, for faster delivery of vital patient information.
What are you looking forward to at AACC?
I’m excited to kick off the week with a press conference on Tuesday, where we’ll highlight key trends in the market, and the products and services that we’re developing to address them. And I’ll be at the Siemens Healthineers booth, hearing from our customers and telling the story of the great work we’re doing to pioneer breakthroughs in healthcare for everyone, everywhere.
I always come back from these conferences feeling reinvigorated – with new ideas and even greater appreciation for our customers and their patients. The AACC makes me proud of what we do and what we offer – we’re improving patient lives every day. When we look at the big picture, it’s about our ability to help clinicians provide the best care possible – through innovation, integration, customization, and AI-powered intelligence. I look forward to sharing that story in Chicago.
Sharon on a laboratory tour of our Tarrytown, NY, R&D facility.
Product availability may vary from country to country and is subject to varying regulatory requirements. Please contact your local representative for availability.